SPOTLIGHT -
ECRI issues new guide to help risk managers in health facilities improve chemotherapy risk management
How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
FDA Approves New Insomnia Therapy: What Pharmacists Need to Know
Daridorexant is approved to treat insomnia in adults who have difficulty with sleep onset or maintenance.
Equity in Healthcare, Improving Access and Quality of Care
A perspective on the CMS Innovation Center roundtable on health equity.
Acetaminophen Reduces Opioid Treatment Duration, Study Shows
Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?
Price Competition As Result of New Drug Approval
The FDA approved efgartigimod, which is being sold under the brand name Vyvgart and could foment price competition with Soliris (eculizumab) and other treatments usually reserved for severe or refractory cases.
Five New Year’s Resolutions for Independent Pharmacy Owners
Let’s raise a glass to all the pharmacy owners who are improving patient health outcomes by providing innovative services.